Penney Financial’s AbbVie ABBV Stock Holding History

Penney Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,252	Closed	-$262K	–	43
2025 Q1	$262K	Hold	1,252	–	–	0.17%	34
2024 Q4	$222K	Hold	1,252	–	–	0.15%	38
2024 Q3	$247K	Hold	1,252	–	–	0.17%	32
2024 Q2	$215K	Hold	1,252	–	–	0.16%	32
2024 Q1	$228K	Buy	+1,252	New	+$216K	0.17%	30

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Penney Financial's ABBV Position: Q2 2025 in Review

Penney Financial sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,252 shares — an estimated $262K sold.

Penney Financial first reported a position in ABBV in Q1 2024 and held it in 5 quarters. The position peaked at $262K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Penney Financial reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
Penney Financial sold 1,252 AbbVie shares in Q2 2025, an estimated $262K.
Penney Financial first reported a position in AbbVie in Q1 2024 and held it in 5 quarters.
Penney Financial's AbbVie position peaked at $262K in Q1 2025.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Penney Financial's 13F filing for Q2 2025, filed 23 Jul 2025.